Results 131 to 140 of about 258,291 (316)

Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia.

PLoS ONE, 2014
Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics.
Ian S Miller, Sebastien Didier, David W Murray, Tia H Turner, Magimairajan Issaivanan, Rosamaria Ruggieri, Yousef Al-Abed, Marc Symons   +7 more
doaj   +1 more source

Unveiling Lactylation: A Novel Frontier in Cancer Stemness and Therapy

Advanced Science, EarlyView.
Tumor metabolism and epigenetic regulation are intrinsically linked. This review highlights lactylation as a pivotal bridge connecting these processes, acting as an active epigenetic effector in cancer stemness. We delineate how lactylation orchestrates the cancer stem cell landscape and evaluate its regulatory networks.
Ting Li, Hongyu Gu, Chang Liu, Yuesheng Lv, Feifei Li, Liang Liang, Jia Yi, Xuanyi Wang, Yi Zhun Zhu, Chuan Xu   +9 more
wiley   +1 more source

Intraventricular Glioblastoma [PDF]

The Neurohospitalist, 2018
Catherine R, Garcia, Mauricio F, Villamar, John L, Villano   +2 more
openaire   +2 more sources

VERIFICATION OF THE EXPERIMENTAL SYSTEM FOR THE APPLICATION OF THE QMR SIGNAL FOR THE TREATMENT OF GLIOBLASTOMA [PDF]

reservedIl glioblastoma è tra i tumori umani quello più aggressivo e con il più alto tasso di recidiva; i pazienti cui viene diagnosticato hanno un’aspettativa di vita di 14-15 mesi nonostante l’intervento chirurgico di rimozione e le cure radio ...
PAVIN, ENRICO
core  

Epigenetic Silencing of RFX7 Defines a Transcriptional Axis Linking Lactate Metabolism to Immune Checkpoint Therapy in Glioblastoma

Advanced Science, EarlyView.
Glioblastoma (GBM) exhibits RFX7 silencing via promoter hypermethylation, which downregulates PIK3IP1 to activate PI3K/AKT signaling, increase lactate accumulation, and enhance histone H4K12 lactylation. This lactylation upregulates PD‐L1/CSF1 expression and drives the immunosuppressive microenvironment formation.
Liying Han, Jinpeng Zhou, Gang Zhu, Fan Chen, Leiyang Li, Wenxing Cui, Fang Sun, Tian Feng, Yue Zhang, Qiang Wang, Shuoyao Ma, Chengxuan Guo, Ziwen Zhang, Kai Wang, Jiahui Wang, Liangbo Wang, Wencong Li, Chenyi Yuan, Haixiao Liu, Liang Wang, Yan Qu   +20 more
wiley   +1 more source

Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing

Advanced Science, EarlyView.
Recent advances in smart nanotechnologies are expanding the toolbox for brain interfacing, from wireless neuromodulation and high‐resolution sensing to targeted delivery within the central nervous system. By combining responsive nanomaterials with bioinspired design, these platforms enable multimodal interactions with neurons and glia, while also ...
Tommaso Curiale, Marie Celine Lefevre, Alessio Carmignani, Maria Cristina Ceccarelli, Matteo Battaglini, Attilio Marino, Gianni Ciofani   +6 more
wiley   +1 more source

Ferroptosis-Related Transcriptional Level Changes and the Role of CIRBP in Glioblastoma Cells Ferroptosis

Biomedicines
Background/Objective: We aimed to elucidate the roles of ferroptosis-associated differentially expressed genes (DEGs) in glioblastoma and provide a comprehensive resource for researchers in the field of glioblastoma cell ferroptosis. Methods: We used RNA
Zijiang Yang, Ting Zhang, Xuanlin Zhu, Xiaobiao Zhang   +3 more
doaj   +1 more source

Materials‐Guided Gene‐Ionizable Lipid Nanoparticles to Reverse Iron‐Associated Immune Resistance in Renal Cancer

Advanced Science, EarlyView.
ABSTRACT Iron overload is a common metabolic disturbance in cancer and contributes to poor outcomes in renal cell carcinoma (RCC), yet its effects on the tumour immune microenvironment remain unclear. Here we identify a previously unrecognized immunosuppressive axis in which iron overload downregulates the palmitoyltransferase ZDHHC12 in CD8+ T cells ...
Xin Jin, Yulong Hong, Chengliang Yin, Wanyang Guo, Yaxuan Wang, Ruijiang Zeng, Ruilin Liu, Zexian Ding, Xinlin Liu, Shangqing Ren, Qiyang Liang, Yaohui Wang, Xu Zhang, João Conde, Yuan Li, Xin Ma, Liangyou Gu   +16 more
wiley   +1 more source

Dual-targeting of CD44 and CD133: a promising therapeutic strategy for glioblastoma treatment

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
The World Health Organization has classified glioblastoma as a grade IV tumor, the highest grade. Despite improvements in neurosurgery, chemotherapy, and radiation therapy, glioblastoma remains one of the most resistant tumors, and it consistently recurs.
Malak Hassn Mesrati
doaj   +1 more source

ENHANCING GLIOBLASTOMA THERAPY: COMBINING DEEP LEARNING SEGMENTATION WITH ROBOTIC HISTOTRIPSY [PDF]

Glioblastoma multiforme (GBM) is the most aggressive and prevalent adult brain cancer, with a median survival of 14 months due to its rapid growth, invasiveness, and resistance to conventional treatments.
Dorosti, Shadi
core